[A rectally administered drug for the treatment of bronchitis]. 1966

H Lotz

UI MeSH Term Description Entries
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal

Related Publications

H Lotz
June 1951, A.M.A. American journal of diseases of children,
H Lotz
April 1951, France Medecine,
H Lotz
January 1990, Revista chilena de pediatria,
H Lotz
June 1954, Bruxelles medical,
H Lotz
April 1988, Pharmacology & toxicology,
H Lotz
December 1987, Clinical neuropharmacology,
H Lotz
January 1986, Voprosy virusologii,
H Lotz
January 1957, Pathologica,
H Lotz
June 1991, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!